Monitoring minimal residual disease in RUNX1-mutated acute myeloid leukemia. Nachmias B, Krichevsky S, Filon D, Even-Or E, et al. Acta Haematol 2022 Aug 5. pii: 000526353. doi: 10.1159/000526353.

Read + Share

Amedeo Smart

Independent Medical Education

Nachmias B, Krichevsky S, Filon D, Even-Or E, et al. Monitoring minimal residual disease in RUNX1-mutated acute myeloid leukemia. Acta Haematol 2022 Aug 5. pii: 000526353. doi: 10.1159/000526353.
PMID: 35933982